Ergomed PLC (LON:ERGO) said its senior independent director Rolf Soderstrom has informed the board of his intention to step down to focus on other business activities.
The company said Soderstrom will remain on the board until September 30 to provide a period of transition.
READ: Ergomed sees earnings ahead of expectations as chairman highlights strong start to 2021
"It has been a pleasure to play a part in Ergomed's success since its strategic transition to a fully services-based business model. Its continued strong growth, track record of effective M&A and the quality of the management team and Board mean it is exceptionally well positioned to deliver on its vision of global leadership in specialised pharmaceutical services addressing unmet medical needs and patient safety", Soderstrom said in a statement.
"Rolf has brought tremendous value to the Ergomed Board since joining in 2019 and made a significant contribution to the growth and success we have shown during the recent period. On behalf of the Board, I would like to thank him for his considerable input and wish him well in all his future endeavours", added Ergomed executive chairman Miroslav Reljanović.